Echocardiographic changes in patients with malignant phase hypertension: The West Birmingham malignant hypertension register

Journal of Human Hypertension

Volumn 19, Issue 1, 2005, Pages 69-75

  Nadar, S ^a   Beevers, D G ^a   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Echocardiography; Malignant hypertension

Indexed keywords

ADULT; AGED; AORTA ROOT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; ESSENTIAL HYPERTENSION; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT ATRIUM; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AORTA; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, MALIGNANT; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; REGISTRIES; STROKE VOLUME;

EID: 12744280979     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001773     Document Type: Article

References (31)

1. McGregor E. Retinal changes in malignant hypertension. BMJ 1986; 292: 235-237.
2. Leishman AW. Hypertension: treated and untreated; a study of 400 cases. BMJ 1959; 15: 1361-1368.
3. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939; 196: 332-343.
4. Leishman AW. Observations on prognosis in hypertension. BMJ 1953; 1: 1131-1135.
5. Isles CG. Factors influencing mortality in malignant hypertension. J Hypertens 1985; 14(Suppl 3): 159-161.
6. Lip GYH, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995; 13: 915-924.
7. Kadiri S, Olutade BO. The clinical presentation of malignant hypertension in Nigerians. J Hum Hypertens 1991; 5: 339-343.
8. Shapiro LM, Mackinnon J, Beevers DG. Echocardiographic features of malignant hypertension. Br Heart J 1981; 46: 374-379.
9. Gardin JM et al. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation 1995; 92: 380-387.
10. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
11. Devereux RB et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
12. Hammond IW et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7: 639-650.
13. Casale PN et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-178.
14. Koren MJ et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
15. Lip GYH, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England. J Hypertens 1994; 12: 1297-1305.
16. Islim IF et al. Prevalence of electrocardiographic left ventricular hypertrophy in malignant hypertension and its correlation with renal function. J Hypertens Suppl 1993; 11(Suppl 5): S106-S107.
17. Nakamura Y et al. Echocardiographic features of left ventricular hypertrophy and contractility in malignant hypertension. J Cardiol 1989; 19: 125-134.
18. Gudbrandsson T, Sivertsson R, Herlitz H, Hansson L. Cardiac involvement in hypertension. A non-invasive study of patients with previous malignant hypertension and 'benign' hypertension. Eur Heart J 1982; 3: 246-254.
19. Tin LL, Beevers DG, Lip GYH. Hypertension, left ventricular hypertrophy, and sudden death. Curr Cardiol Rep 2002; 4: 449-457.
20. Yildirir A, Batur MK, Oto A. Hypertension and arrhythmia: blood pressure control and beyond. Europace 2002; 4: 175-182.
21. Shapiro LM, Beevers DG. Malignant hypertension: cardiac structure and function at presentation and during therapy. Br Heart J 1983; 49: 477-484.
22. Okin PM et al. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. Am J Hypertens 2002; 15: 663-671.
23. Stanton AV et al. Ethnic differences in carotid and left ventricular hypertrophy. J Hypertens 2002; 20: 539-543.
24. Chapman N et al. Ethnic and gender differences in electrocardiographic QT length and QT dispersion in hypertensive subjects. J Hum Hypertens 2000; 14: 403-405.
25. Chapman JN et al. Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient. Am J Hypertens 1999; 12: 437-442.
26. Lip GYH, Felmeden DC, Li-Saw-Hee FL, Beevers DG. Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'? Eur Heart J 2000; 21: 1653-1665.
27. Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol 2003; 91: 9C-14G.
28. Messerli FH, Grodzicki T. Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death. Eur Heart J 1992; 13(Suppl D): 66-69.
29. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Eng J Med 1987; 317: 787-792.
30. Verdecchia P et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003; 41: 218-223.
31. Webster J, Petrie JC, Jeffers TA, Lovell HG. Accelerated hypertension-patterns of mortality and clinical factors affecting outcome in treated patients. Q J Med 1993; 86: 485-493.